Medius Holdings Co., Ltd. (3154) AI Stock Analysis

• Market Cap: ¥19.28B
• Dividend Yield: 2.19%
• Average Volume (3M): 58.08K
• Price to Earnings (P/E): 14.2
• Beta (1Y): 0.61
• Revenue Growth: 14.12%
• EPS Growth: 56.92%
• Country: JP
• Employees: 2,517
• Sector: Healthcare
• Sector Strength: 37
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 43.40
• Shares Outstanding: 22,238,216
• 10 Day Avg. Volume: 23,920
• 30 Day Avg. Volume: 58,080
• PEG Ratio: -0.64
• Price to Book (P/B): 1.03
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 63.81
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,072.00
• Price Target Upside: 23.64% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 62 Neutral
• Price Target: ¥986.00 ▲(13.73%Upside)

Medius Holdings Co., Ltd.'s overall stock score reflects a solid financial foundation with strong revenue growth and stable profitability, although cash flow fluctuations present a risk. The technical analysis indicates a bearish trend, impacting the score negatively. Valuation metrics are reasonable, providing a balanced outlook.

Medius Holdings Co., Ltd. Business Overview & Revenue Model

Company Description

Medius Holdings Co., Ltd. (3154) is a Japan-based company primarily engaged in the wholesale sector, focusing on medical products and healthcare services. The company offers a broad range of medical supplies, equipment, and related services to healthcare institutions, clinics, and other medical facilities. Medius Holdings aims to support the healthcare industry by providing high-quality products and innovative solutions that enhance patient care and operational efficiency.

How the Company Makes Money

Medius Holdings Co., Ltd. generates revenue through the wholesale distribution of medical supplies and equipment to various healthcare providers and institutions. The company's key revenue streams include the sale of consumable medical products, surgical instruments, and diagnostic devices. Additionally, Medius Holdings may engage in partnerships with medical manufacturers to distribute exclusive products, enhancing its market presence and competitiveness. The company benefits from long-term contracts with hospitals and clinics, ensuring a steady income flow and fostering strong customer relationships. These factors, along with the growing demand for healthcare services, contribute significantly to the company's earnings.

Medius Holdings Co., Ltd. Financial Statement Overview

Summary

Medius Holdings Co., Ltd. demonstrates strong revenue growth and consistent profitability margins. However, cash flow fluctuations, particularly in free cash flow, pose a risk that needs attention for sustained financial health.

Income Statement

Medius Holdings Co., Ltd. shows a strong revenue growth trajectory with recent TTM data indicating a rise in total revenue. The gross profit margin is stable, reflecting efficient cost management. However, the net profit margin has shown some volatility, which could be a concern. EBIT and EBITDA margins are consistent, suggesting operational stability.

Balance Sheet

The company's balance sheet reveals a moderate debt-to-equity ratio, indicating a balanced approach to leverage. The return on equity is healthy, demonstrating effective utilization of shareholder funds. The equity ratio is satisfactory, reflecting a solid asset base supported by equity.

Cash Flow

Cash flow analysis shows fluctuations in free cash flow, influenced by capital expenditure dynamics. Despite operating cash flow being zero in the latest TTM data, previous periods have shown positive cash flow generation. The company needs to focus on sustaining free cash flow for long-term stability.

Breakdown	TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	275.78B	259.79B	239.05B	221.69B	246.79B	210.39B
Gross Profit	32.28B	31.09B	29.31B	27.42B	25.20B	22.27B
EBITDA	3.62B	3.86B	4.27B	3.80B	4.14B	2.11B
Net Income	1.03B	1.12B	1.50B	1.87B	2.07B	951.36M
Balance Sheet
Total Assets	119.80B	114.83B	97.46B	92.95B	84.44B	69.97B
Cash, Cash Equivalents and Short-Term Investments	14.00B	13.66B	10.36B	9.11B	12.67B	8.54B
Total Debt	25.23B	24.17B	19.57B	17.82B	11.60B	9.31B
Total Liabilities	99.82B	95.09B	78.88B	75.65B	68.59B	56.10B
Stockholders Equity	19.98B	19.74B	18.57B	17.31B	15.84B	13.87B
Cash Flow
Free Cash Flow	0.00	261.12M	300.65M	-8.49B	2.93B	185.14M
Operating Cash Flow	0.00	1.92B	1.22B	-3.90B	6.85B	1.17B
Investing Cash Flow	0.00	-2.67B	-862.94M	-4.82B	-4.62B	138.45M
Financing Cash Flow	0.00	4.01B	862.90M	5.21B	1.90B	787.57M

Medius Holdings Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 867.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3154, the sentiment is Negative. The current price of 867 is below the 20-day moving average (MA) of 872.70, below the 50-day MA of 912.37, and below the 200-day MA of 871.48, indicating a bearish trend. The MACD of -13.73 indicates Negative momentum. The RSI at 42.93 is Neutral, neither overbought nor oversold. The STOCH value of 30.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3154.

Medius Holdings Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4556	84 Outperform	¥5.16B	8.29		2.54%	4.93%	-0.26%
7980	76 Outperform	¥5.75B	7.36		1.86%	8.60%	33.64%
7743	72 Outperform	¥14.38B	12.97		3.16%	2.58%	-53.08%
3154	62 Neutral	¥19.28B	14.17		2.19%	14.12%	56.92%
7702	61 Neutral	¥10.65B	120.55		3.90%	6.83%	―
7979	61 Neutral	¥72.90B	16.62		2.40%	15.55%	42.14%
Sector *	52 Neutral	$7.61B	0.10	-63.03%	2.08%	16.34%	0.32%

Medius Holdings Co., Ltd. Corporate Events

Medius Holdings Completes Logistics Division Reorganization

Medius Holdings Co., Ltd. has completed the internal reorganization of its logistics division by transferring it to a wholly owned subsidiary, now renamed Mediris Logistics Co., Ltd. This company split is expected to have an immaterial impact on the company’s overall business results, indicating a strategic move to streamline operations without disrupting financial performance.

Medius Holdings Reports Strong Q3 Financial Growth Amid Strategic Expansion

Medius Holdings Co., Ltd. reported significant financial growth for the third quarter ended March 31, 2025, with net sales increasing by 13.7% and operating profit rising by 22.6% compared to the previous year. The inclusion of two new companies in its consolidation scope reflects Medius Holdings’ strategic expansion, potentially enhancing its market position and offering improved services to stakeholders.